Skip to main content


Table 4 Comparison in relative percentage of DDDs of oral antibacterials before and after intervention

From: An outpatient antibacterial stewardship intervention during the journey to JCI accreditation

Oral antibacterials Relative percentage of DDDs
  First phase (March, 2012) Second phase (March, 2013)
Cefuroxime axetil tablets# 10.6% 13.2%
Levofloxacin tablets# 9.6% 12.6%
Moxifloxacin tablets# 8.6% 9.1%
Amoxicillin# 8.1% 11.4%
Cefdinir capsules 7.0% 7.2%
Clarithromycin tablets# 5.7% 7.4%
Cefradine capsules# 3.1% 1.8%
Ornidazole tablets# 2.3% 2.8%
Cefaclor SR tablets & Cefaclor capsules# 1.8% 9.3%
Cefprozi tablets# 1.72% 1.2%
Clindamycin palmitate tablets# 0.48% 1.2%
  1. Notes: # P < 0.01 (first phase vs second phase). Differences between the two phases were tested for statistical significance using Pearson’s Chi-square test. A P value < 0.01 was considered to be highly significant. DDDs: number of of defined daily doses (total dose consumed/defined daily dose). Relative percentage of DDDs: DDDs of individual antibacterial divided by the sum of DDDs of all antibacterials. SR: sustained release.